Last reviewed · How we verify

Chlorhydrate de morphine

Assistance Publique - Hôpitaux de Paris · Phase 2 active Small molecule

Chlorhydrate de morphine is a potent opioid analgesic that acts as a mu-opioid receptor agonist.

Chlorhydrate de morphine is a potent opioid analgesic that acts as a mu-opioid receptor agonist. Used for Pain management in cancer patients, Acute pain management.

At a glance

Generic nameChlorhydrate de morphine
SponsorAssistance Publique - Hôpitaux de Paris
Drug classopioid
Targetmu-opioid receptor
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 2

Mechanism of action

By binding to the mu-opioid receptor, morphine exerts its analgesic effects by modulating the release of neurotransmitters such as dopamine and endorphins. This results in a decrease in the perception of pain. Additionally, morphine can also produce sedation, euphoria, and respiratory depression as side effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results